Recent Security Class Actions

Revance Therapeutics Inc. Common Stock (NASDAQ: RVNC)

52 Days left to seek lead plaintiff status.

Company Name:Revance Therapeutics Inc. Common Stock
Stock Symbol:NASDAQ: RVNC
Class Period Start:02/29/2024
Class Period End (inclusive):12/06/2024
Filing Deadline:03/04/2025

The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges Defendants made false and/or misleading statements and/or failed to disclose that: (i) Revance was in material breach of the Distribution Agreement; (ii) the foregoing subjected the Company to an increased risk of litigation, as well as monetary and reputational harm; (iii) all the foregoing increased the risk that the Tender Offer would be delayed and/or amended; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Revance Therapeutics Inc. Common Stock (NASDAQ: RVNC) Claim Form

Name(Required)
Address
This field is for validation purposes and should be left unchanged.